Last10K.com

Hutchmed (HCM) SEC Filing 6-K Foreign Issuer Report for the period ending Thursday, March 31, 2022

Hutchison China Meditech Ltd

HISTORY TOOLS
CIK: 1648257 Ticker: HCM

View differences made from one to another to evaluate Hutchison China Meditech Ltd's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Hutchison China Meditech Ltd.

Continue

Assess how Hutchison China Meditech Ltd's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Hutchison China Meditech Ltd's Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Material Contracts, Statements, Certifications & more

Hutchison China Meditech Ltd provided additional information to their SEC Filing as exhibits

Exhibit 99.1: Additional Exhibits
Ticker: HCM
CIK: 1648257
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001648257-22-000031
Submitted to the SEC: Thu Mar 31 2022 6:26:35 AM EST
Accepted by the SEC: Thu Mar 31 2022
Period: Thursday, March 31, 2022
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/hcm/0001648257-22-000031.htm